Phase 1b/2 study of combination ¹⁷⁷Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.

Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC (original) (raw)